You Love Dogs? Then Don’t Clone Them
By Jessica Pierce,
New York Times
| 03. 06. 2018
Why, people want to know, did Barbra Streisand decide to clone Samantha, her coton de tulear? What would compel someone to spend $50,000 or more to create a genetic replica of a pet dog?
In the recent buzz over pet cloning, the issue has largely been framed as a personal decision, albeit a quirky one. But the decision to clone is not merely personal. There are broader ramifications for dogs, not only for the large group of dogs we call pets but also for a whole canine underclass that remains largely invisible to us but whose bodies serve as a biological substrate for cloning research and industry.
Clones like Ms. Streisand’s dogs Miss Violet and Miss Scarlett don’t materialize out of thin air but require the help of a whole team of female dogs. The cloning process begins with a group of dogs that will “donate” their eggs, a process that involves pharmaceutical manipulation of hormone levels and a surgical egg-harvesting procedure. Once removed from the donor dogs’ ovaries, the eggs will be enucleated — the unwanted DNA from the...
Related Articles
By Diaa Hadid and Shweta Desai, NPR | 01.29.2026
MUMBRA, India — The afternoon sun shines on the woman in a commuter-town café, highlighting her almond-shaped eyes and pale skin, a look often sought after by couples who need an egg to have a baby.
"I have good eggs,"...
By George Janes, BioNews | 01.12.2026
A heart attack patient has become the first person to be treated in a clinical trial of an experimental gene therapy, which aims to strengthen blood vessels after coronary bypass surgery.
Coronary artery bypass surgery is performed to treat...
By Staff, ScienceDaily | 01.05.2026
Scientists at UNSW Sydney have developed a new form of CRISPR technology that could make gene therapy safer while also resolving a decades-long debate about how genes are switched off. The research shows that small chemical markers attached to DNA
...
Following a long-standing CGS tradition, we present a selection of our favorite Biopolitical Times posts of the past year.
In 2025, we published up to four posts every month, written by 12 authors (staff, consultants and allies), some in collaboration and one simply credited to CGS.
These titles are presented in chronological order, except for three In Memoriam notices, which follow. Many more posts that are worth your time can be found in the archive. Scroll down and “VIEW...
